As health plans look for new ways to manage rising costs tied to members with multiple chronic conditions, one factor continues to be overlooked: menopause and the surrounding years.
We tend to talk about menopause as if it’s a discrete life stage to be handled on its own, but for many women, the extreme physiologic changes that precede and follow menopause occur while they are already managing conditions like diabetes, hypertension, cardiovascular disease, and depression. New, difficult-to-manage health burdens are layered on top of existing conditions, often making each one harder to control.
That’s where complexity and cost begin to intensify for health plans and the women they serve.
More than half of U.S. adults live with multiple chronic conditions, and prevalence increases with age. At the same time, more than 80% of women experiencing menopause symptoms do not seek or get adequate medical care. Current social media movements are also amplifying non-traditional therapies for menopausal symptoms. Together, these trends point to a largely unmanaged layer of health risk within an already high-cost population.
Clinically, menopause is not neutral. Hormonal shifts can influence cardiovascular risk, metabolic function, bone density, sleep, and mental health in an otherwise healthy female. For someone already managing chronic disease, those changes can disrupt stability and complicate treatment plans in ways that aren’t always immediately visible but show up over time in outcomes and utilization.
One of the most overlooked pressure points is medication management. Women may begin hormone therapy while continuing treatment for multiple chronic conditions, often alongside over-the-counter supplements. Without coordination, it’s easy to end up with drug interactions, overlapping therapies, or regimens that are simply too complex to follow consistently.
This is where we see safe medication use and adherence break down and costs start to rise.
Picture a woman in her late 40s managing hypertension and prediabetes. She begins experiencing peri-menopausal weight gain and other symptoms that disrupt her sleep and increase anxiety, so she starts hormone therapy and adds over-the-counter medications and supplements to manage symptoms. At the same time, her blood pressure becomes harder to control, her medication routine becomes more complex, and she begins missing doses. What started as manageable conditions becomes a cycle of poor sleep, inconsistent adherence, and escalating clinical risk — often without a single point of coordination.
Unmanaged menopause symptoms are associated with increased outpatient visits, diagnostic testing, and acute care episodes. Estimates put menopause-related healthcare costs at more than $24 billion annually. While managing peri- and post-menopausal symptoms in isolation is difficult enough, amplified utilization in an already high-risk population leads to increased costs and worse outcomes.
And yet, most care models aren’t built to keep up with this reality. Condition management programs are still largely structured around single diseases. Menopause solutions, when they exist, often focus on symptom relief without accounting for the broader clinical picture. Neither approach reflects how women actually experience this complex health experience.
Programs place the burden on women to manage complexity on their own. Fragmentation makes it harder to engage, harder to adhere, and harder to sustain meaningful change.
There is a more effective path forward. We need to start treating menopause as part of a multi-condition care strategy, not as a separate category.
For health plans, that means incorporating menopause into risk stratification, care planning, and engagement strategies for midlife populations. It means recognizing that a woman managing multiple conditions will need coordinated support, not a series of disconnected interventions.
Pharmacist-led guidance can play a critical role here, particularly in identifying drug interactions, simplifying regimens, and supporting adherence across therapies. And when that clinical support is paired with ongoing, human-centered engagement, whether through coaching or digital tools, it becomes possible to reinforce the daily behaviors that drive outcomes.
Adding another benefit is not the solution. What health plans and their members need is care that reflects the full complexity of their health — care that connects conditions, medications, and daily realities rather than treating them in isolation.
As the industry continues to move toward value-based care and more integrated population health strategies, menopause should not be treated as a standalone issue. It is part of the lived clinical reality for a large and growing population. Addressing it more thoughtfully is not just an opportunity to reduce cost, but to provide more coordinated, effective care for women navigating an already complex health journey.
Photo: Toa55, Getty Images
Leslie Helou has more than 20 years of experience across clinical pharmacy fields, including more than a decade in the life sciences sector, where she held leadership roles at Upsher-Smith Laboratories in medical portfolio strategy, project management, and patient, provider, and advocacy relations. She also spent a decade designing clinical pharmacy services, population health strategies, and health outcomes approaches. At MOBE, Leslie leads the design of value-based clinical initiatives to improve outcomes, ensure safe and appropriate medication use, and reduce total care costs for populations impacted by fragmented health care. A Doctor of Pharmacy graduate from the University of Minnesota College of Pharmacy, Leslie completed a multi-year post-graduate residency in pharmaceutical care and leadership. She’s a Board of Trustees member for the Minnesota Pharmacists Foundation and a former adjunct faculty member at the University of Minnesota.
This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.
